Development of theranostic silica nanoparticles for quantitative 19F MRI and Boron Neutron Capture Therapy (BNCT) against cancer.

Authors

Institutions

Publication Details

Journal
ORBi UMONS
Published
2025-01-28
Primary Topic
Boron Compounds in Chemistry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of theranostic silica nanoparticles for quantitative 19F MRI and Boron Neutron Capture Therapy (BNCT) against cancer.

Thomas Vangijzegem, Sarah Garifo, Dimitri Stanicki, Sophie Laurent et al.
ORBi UMONS
Boron Compounds in Chemistry
article

Development of theranostic silica nanoparticles for quantitative 19F MRI and Boron Neutron Capture Therapy (BNCT) against cancer.

Thomas Vangijzegem, Sarah Garifo, Dimitri Stanicki, Sophie Laurent, Amandine Maes, Robert Muller, Pierre Ernotte
article en

Abstract

No abstract available for this paper.
ORBi UMONS
University of Mons (BE), Laboratoire de Chimie Organique (FR)
Openalex Percentile: Top 26%
Boron Compounds in Chemistry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of theranostic silica nanoparticles for quantitative 19F MRI and Boron Neutron Capture Therapy (BNCT) against cancer. — Thomas Vangijzegem, Sarah Garifo, et al. · ORBi UMONS (2025) | TGRS Research Map | TGRS